APAC Monosodium Glutamate Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by form

1.4.2. Market size breakdown, by distribution channel

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by end use

1.4.5. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Volume

1.5.2. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. APAC Market

6.1. Overview

6.2. Market Volume, by Form (2019–2030)

6.3. Market Revenue, by Form (2019–2030)

6.4. Market Volume, by Distribution Channel (2019–2030)

6.5. Market Revenue, by Distribution Channel (2019–2030)

6.6. Market Volume, by Application (2019–2030)

6.7. Market Revenue, by Application (2019–2030)

6.8. Market Volume, by End Use (2019–2030)

6.9. Market Revenue, by End Use (2019–2030)

6.10. Market Volume, by Country (2019–2030)

6.11. Market Revenue, by Country (2019–2030)

Chapter 7. Competitive Landscape

7.1. List of Market Players and their Offerings

7.2. Competitive Benchmarking of Key Players

7.3. Product Benchmarking of Key Players

7.4. Recent Strategic Developments

Chapter 8. Company Profiles

8.1. Ajinomoto Co. Inc.

8.1.1. Business overview

8.1.2. Product and service offerings

8.1.3. Key financial summary

8.2. Vedan International (Holdings) Limited.

8.2.1. Business overview

8.2.2. Product and service offerings

8.2.3. Key financial summary

8.3. KYOWA HAKKO BIO CO.LTD.

8.3.1. Business overview

8.3.2. Product and service offerings

8.3.3. Key financial summary

8.4. Shandong Linghua MSG Co. Ltd

8.4.1. Business overview

8.4.2. Product and service offerings

8.4.3. Key financial summary

8.5. Shandong Shenghua Group

8.5.1. Business overview

8.5.2. Product and service offerings

8.5.3. Key financial summary

8.6. Jianyang Wuyi MSG Co. Ltd.

8.6.1. Business overview

8.6.2. Product and service offerings

8.6.3. Key financial summary

8.7. Xinjiang Fufeng Biotechnologies Co.

8.7.1. Business overview

8.7.2. Product and service offerings

8.7.3. Key financial summary

8.8. Meihua Holdings Group Co. Ltd

8.8.1. Business overview

8.8.2. Product and service offerings

8.8.3. Key financial summary

8.9. Kerry Group plc

8.9.1. Business overview

8.9.2. Product and service offerings

8.9.3. Key financial summary

Chapter 9. Appendix

9.1. Abbreviations

9.2. Sources and References

9.3. Related Reports